Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Takeda’s Strategic Run Up To Nycomed

Jul 30 2012

Related Content

With URL, Takeda Looks To Become U.S. Gout Therapy Provider Of Choice

Apr 11 2012

Forest Acquires U.S. Rights To Nycomed's Oral COPD Drug Daxas

Aug 10 2009

Forest’s Respiratory Pipeline: Can It Open The Revenue Airway?

Jun 26 2012

Takeda Finally Reveals €9.6B Nycomed Acquisition; Sheds Dermatology Business, But Otherwise Set On Retention

May 19 2011

With Nycomed, Takeda Satifies Both Strategic And Financial Objectives

Jun 01 2011

Takeda's Global Ambition

Jun 01 2008

Takeda Buys Abbott’s Stake In TAP Joint Venture

Mar 19 2008

Related Companies

Abbott

Takeda Pharmaceutical Co. Ltd.

Takeda Pharmaceutical Co. Ltd.

Eisai Co., Ltd.

Ligand Pharmaceuticals, Inc.

Daiichi Sankyo Co., Ltd.

Ranbaxy Laboratories Limited

Astellas Pharma, Inc.

Takeda Pharmaceutical Co. Ltd.

Takeda Pharmaceutical Co. Ltd.

Affymax, Inc.

H. Lundbeck A/S

Seagen Inc.

Amgen, Inc.

Takeda Pharmaceutical Co. Ltd.

Plexxikon, Inc.

Alnylam Pharmaceuticals Inc.

University College London

Sanford Burnham Prebys Medical Discovery Institute

Translational Sciences, Inc.

Bayer AG

Solvay SA

Altana AG

Forest Laboratories, Inc.

Merck & Co., Inc.

Merck & Co., Inc.

NPS Pharmaceuticals, Inc.

GSK plc

Sanofi

Juventas Therapeutics, Inc.

CellCentric Ltd.

Nxera Pharma Co., Ltd.

Takeda Pharmaceutical Co. Ltd.

Takeda Pharmaceutical Co. Ltd.

Multilab Indústria e Comércio de Produtos Farma

AMAG Pharmaceuticals Inc.

Additional Topics

Business Strategies Deals Leadership Emerging Markets BioPharmaceutical

More from Business Strategy

More from In Vivo

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window